These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7636844)

  • 41. Dimeric 1,4-dihydropyridines as calcium channel antagonists.
    Joslyn AF; Luchowski E; Triggle DJ
    J Med Chem; 1988 Aug; 31(8):1489-92. PubMed ID: 2840498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and calcium channel antagonist activities of 3-nitrooxyalkyl, 5-alkyl 1,4-dihydro-2,6-dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3, 5-pyridinedicarboxylates.
    Miri R; Niknahad H; Vesal G; Shafiee A
    Farmaco; 2002 Feb; 57(2):123-8. PubMed ID: 11902654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
    Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
    J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonists.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1990 Jun; 33(6):1805-11. PubMed ID: 2342074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microwave-assisted synthesis and spasmolytic activity of 4-indolylhexahydroquinoline derivatives.
    El-Khouly A; Gündüz MG; Cengelli C; Simşek R; Erol K; Safak C; Yıldırım SO; Butcher RJ
    Drug Res (Stuttg); 2013 Nov; 63(11):579-85. PubMed ID: 23804251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey.
    Nakajima M; Adachi I; Ueda M
    Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-3,5-pyridinedicarboxylates.
    Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Wynn H; Triggle CR; Knaus EE
    J Med Chem; 1986 Dec; 29(12):2524-9. PubMed ID: 3783612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
    Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
    Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of analogs of the 1,4-dihydropyridine tiamdipine in cardiac and smooth muscle.
    Galletti F; Zheng W; Gopalakrishnan M; Rutledge A; Triggle DJ
    Eur J Pharmacol; 1991 Mar; 195(1):125-9. PubMed ID: 2065707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of [3H]isradipine binding to L-type calcium channels by the optical isomers of isoflurane. Lack of stereospecificity.
    Moody EJ; Harris B; Hoehner P; Skolnick P
    Anesthesiology; 1994 Jul; 81(1):124-8. PubMed ID: 8042780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
    Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester.
    Muto K; Kuroda T; Kawato H; Karasawa A; Kubo K; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1662-5. PubMed ID: 3219137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and calcium channel antagonist activity of dialkyl 4- (dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylates.
    Dagnino L; Li-Kwong-Ken MC; Wynn H; Wolowyk MW; Triggle CR; Knaus EE
    J Med Chem; 1987 Apr; 30(4):640-6. PubMed ID: 3560157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents.
    Shafiee A; Rastkary N; Jorjani M
    Arzneimittelforschung; 2002; 52(7):537-42. PubMed ID: 12189777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, spectroscopic, DFT, and molecular docking studies on 1,4-dihydropyridine derivative compounds: a combined experimental and theoretical study.
    Karthick R; Velraj G; Pachamuthu MP; Karthikeyan S
    J Mol Model; 2021 Dec; 28(1):5. PubMed ID: 34889990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
    Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
    Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
    Atwal KS; Rovnyak GC; Schwartz J; Moreland S; Hedberg A; Gougoutas JZ; Malley MF; Floyd DM
    J Med Chem; 1990 May; 33(5):1510-5. PubMed ID: 2329573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.